InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Pruzanski Mark, Director. Officer active across 1 companies, notably Intercept Pharmaceuticals, INC.. Cumulatively, 16 filings have been published. The latest transaction was filed on 30 November 2021 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations16 total
€93,5376,138 shares@ €15.238913.1% of flow
Common Stock
SEC:0001104659-21-145908·
€93,5376,138 shares@ €15.23896.5% of flow
Common Stock
SEC:0001104659-21-145908:0·
€88,5746,138 shares@ €14.430512.4% of flow
Common Stock
SEC:0001104659-21-132983·
€88,5746,138 shares@ €14.43056.2% of flow
Common Stock
SEC:0001104659-21-132983:0·
€78,7256,136 shares@ €12.8311.0% of flow
Common Stock
SEC:0001104659-21-122560·
€78,7256,136 shares@ €12.835.5% of flow
Common Stock
SEC:0001104659-21-122560:0·
€77,4906,138 shares@ €12.624610.8% of flow
Common Stock
SEC:0001104659-21-112144·
€77,4906,138 shares@ €12.62465.4% of flow
Common Stock
SEC:0001104659-21-112144:0·
€89,1826,138 shares@ €14.529612.5% of flow
Common Stock
SEC:0001104659-21-099031·
€89,1826,138 shares@ €14.52966.2% of flow
Common Stock
SEC:0001104659-21-099031:0·
€103,3476,136 shares@ €16.842714.5% of flow
Common Stock
SEC:0001104659-21-088399·
€103,3476,136 shares@ €16.84277.2% of flow
Common Stock
SEC:0001104659-21-088399:0·
€83,7156,138 shares@ €13.638811.7% of flow
Common Stock
SEC:0001104659-21-075896·
€83,7156,138 shares@ €13.63885.9% of flow
Common Stock
SEC:0001104659-21-075896:0·
€100,1146,138 shares@ €16.31067.0% of flow
Common Stock
SEC:0001104659-21-061181:0·
€100,1146,138 shares@ €16.310614.0% of flow
Common Stock
SEC:0001104659-21-061181·
16 of 16 declarations
About Pruzanski Mark
Mark Pruzanski is an executive at INTERCEPT PHARMACEUTICALS, INC.
